T-cell lymphoma (peripheral, relapsed or refractory) - romidepsin: EIA - scoping
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: Institute's response to consultee and commentator comments on the draft scope and provisional matrix
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final matrix
Lymphoma (peripheral, T-cell, relapsed, refractory) - romidepsin: final scope
Appendix B - draft scope for consultation (pre-referral) - July 2011
Appendix C - provisional matrix (pre-referral) - July 2011